Ilker Tasci

TL;DR: The results indicate that hyperglycemia causes an increase in plasma visfatin levels and, as in people with T2DM but not with IGT, this increase gets more prominent as the glucose intolerance worsens.

TL;DR: Plasma apelin is reduced in newly diagnosed and untreated patients with type 2 diabetes mellitus having no confounders and Regulation of circulating apelin and adiponectin seems to be in the same manner in patients with T2DM.

TL;DR: The authors are queried whether they can present some new results by categorizing the patients with NASH and SS according to metabolic confounders such as DM, impaired glucose tolerance, blood pressure and lipid profile, which may provide the readers clearer information related to the mechanism of non-alcoholic fatty liver disease.

TL;DR: A group of newly diagnosed and untreated 30 young hypertensive men and 30 healthy controls investigated the role of ADMA and apelin in the pathogenesis of essential hypertension, finding the levels were significantly lower and the ADMA levels higher in the patients.

TL;DR: Low apelin levels in hypercholesterolemia seem associated with insulin resistance, which needs to be investigated in larger populations as well as in other atherosclerotic conditions.